Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

11.5%

3 terminated/withdrawn out of 26 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
14(60.9%)
Phase 1
4(17.4%)
Early Phase 1
3(13.0%)
Phase 2
2(8.7%)
23Total
N/A(14)
Phase 1(4)
Early Phase 1(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials
NCT05970575Phase 2Terminated

Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury

Role: lead

NCT05227820Phase 2Completed

Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of Dementia

Role: lead

NCT04250376Not ApplicableUnknown

The Use of Transcranial Focused Ultrasound for the Treatment of Neurodegenerative Dementias

Role: lead

NCT04250441Not ApplicableUnknown

The Use of Transcranial Focused Ultrasound for the Treatment of Depression and Anxiety

Role: lead

NCT04063514Not ApplicableEnrolling By Invitation

The Use of Focused Ultrasound and DCE K-trans Imaging to Evaluate Permeability of the Blood-Brain Barrier

Role: lead

NCT03232463Enrolling By Invitation

Study for the Evaluation of the Feasibility of Applying Advanced MRI Scanning in Clinical Practice

Role: lead

NCT05475340Early Phase 1Unknown

Open Label Study for the Use of Transcranial Ultrasound Treatment of Tremor

Role: lead

NCT04205539Phase 1Withdrawn

Lymphatic System Health in Alzheimer's Disease

Role: lead

NCT04066933Unknown

Forms of Cervical Brachial Syndrome Treated With Plasma Concentrate Enriched for A2M

Role: lead

NCT04770350Early Phase 1Unknown

Open Label Study for the Use of Transcranial Ultrasound for Treatment of Age-Related Frailty

Role: lead

NCT04202783Not ApplicableSuspended

The Use of Exosomes In Craniofacial Neuralgia

Role: lead

NCT04775875Not ApplicableUnknown

The Use of Transcranial Ultrasound Treatment of Obsessive-Compulsive Disorder

Role: lead

NCT04489082Not ApplicableUnknown

Near-Infrared Laser Stimulation for Various Neurological Conditions

Role: lead

NCT04202770Not ApplicableSuspended

Focused Ultrasound and Exosomes to Treat Depression, Anxiety, and Dementias

Role: lead

NCT04497350Not ApplicableUnknown

Transcranial Magnetic Stimulation vs Theta Burst Stimulation in Major Depressive Disorder

Role: lead

NCT04064879Not ApplicableSuspended

The Use of Autologous Mesenchymal Stem Cell Preparation for Treatment of Refractory Migraine

Role: lead

NCT04497363Not ApplicableEnrolling By Invitation

Focused Ultrasound for the Treatment of ADHD Symptoms

Role: lead

NCT04209023Not ApplicableSuspended

The Use of Navigated Transcranial Magnetic Stimulation (nTMS) in the Inhibition of Neurofunctional Regions of Interest

Role: lead

NCT03232489Unknown

Study for the Evaluation of the Feasibility of Applying Advanced MRI Scanning in Pediatric Clinical Practice

Role: lead

NCT04485208Not ApplicableUnknown

Focused Ultrasound for the Treatment of Neuropathic Pain

Role: lead